NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC MP IMAGING SYSTEM (PCA-NCI-09799)
Archived on October 3, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EDT
- Posted
- September 25, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Place of performance
- Bethesda, Maryland, 20814
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- PCA-NCI-09799
- Notice ID
- f7f46354ebd94e7aa34e8d62951dbc41
Description
Title: PROCUREMENT OF THE BIO-RAD CHEMIDOC MP IMAGING SYSTEM
This is a Notice of Intent (NOI), not a request for proposal. The National Cancer Institute intends to negotiate on an other-than-full-and-open competition basis with Bio-Rad Laboratories, Inc., 1000 Alfred Nobel Dr., Hercules, CA 94547-1811 for a Bio-Rad ChemiDoc™ MP Imaging System to function with an existing Bio-Rad Mini-Protean and Criterion electrophoresis system to produce a more capable and efficient system for its ongoing clinical pharmacology and translational research studies.
While this pre-solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Bio-Rad Laboratories, Inc. is the owner and developer of the required piece of equipment currently being utilized by NCI per compatibility requirements. However, vendors who believe that they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact prior to the closing date and time of this notice. Interested parties should clearly address the challenge of integrating with existing Bio-Rad electrophoresis workflows and Bio-Rad Stain-Free workflows. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement by referencing “PCA-NCI-09799.”
The statutory authority for this sole source requirement is 41 U.S.C. 3204(b)(2) as implemented by FAR Overhaul 12.102(a) only one source is available. THIS IS NOT A REQUEST FOR PROPOSAL.
All responsible sources that could provide comparable products may submit a capability statement via email to Christine Biser at:
ChristineBi@mail.nih.gov by 12:00 pm EASTERN Daylight Time, Wednesday, September 16, 2026.
Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Christine Biser at ChristineBi@mail.nih.gov.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
H.7 Award Notice.pdf
46 KBAdded in Special Notice version 3Posted
Lifecycle
- 1Version 1Special NoticeArchived
NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC MP IMAGING SYSTEM (PCA-NCI-09799)
- 3Version 3Special NoticeArchivedCurrent
NOTICE OF INTENT TO SOLE SOURCE - PROCUREMENT OF THE BIO-RAD CHEMIDOC MP IMAGING SYSTEM (PCA-NCI-09799)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
PCA-NCI-09799
Archive Date
Oct 3, 2026
Office Address
Bethesda, MD, 20892, US